SCHEMBL16638026

SCHEMBL16638026

N#CC1CCCCC1(C(N)=O)C1CC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27764954 0.69 EPHX1 (0.31) —
SCHEMBL3388937 0.63 KDM4E (0.31) KDM4EMAPT
SCHEMBL28760194 0.63 — —
SCHEMBL11121679 0.63 KDM4E (0.36) KDM4EMAPT
SCHEMBL9308229 0.63 KDM4E (0.36) KDM4EMAPT
SCHEMBL2959651 0.63 UGT2B7 (0.33) —
SCHEMBL10432677 0.62 AKR1C1 (0.45) —
SCHEMBL2979879 0.62 KDM4E (0.34) KDM4EMAPT
SCHEMBL3207905 0.62 TSHR (0.37) —
SCHEMBL812033 0.62 TSHR (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3104705-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-12-21 — — EP disclosed
EP-3055314-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-08-17 — — EP disclosed
WO-2015123089-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-08-20 — — WO disclosed
WO-2015051479-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-04-16 — — WO disclosed
WO-2015054089-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-04-16 — — WO disclosed
Send feedback